During the past decade, Nihon Pharmaceutical Co., Ltd conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Nihon Pharmaceutical Co., Ltd" are "Gastric Cancer" (2 trials), "Chronic Inflammatory Demyelinating Polyneuropathy" (1 trials), "Colon Nos Polypectomy Tubular Adenoma" (1 trials), "Gastric Adenoma" (1 trials) and "Guillain-Barré Syndrome" (1 trials). Many other conditions were trialed in "Nihon Pharmaceutical Co., Ltd" in a lesser frequency.

Most popular intervention types in "Nihon Pharmaceutical Co., Ltd" are "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "NPB-01" (3 trials), "Menthol" (2 trials), "Intravenous immunoglobulin" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Nihon Pharmaceutical Co., Ltd" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Nihon Pharmaceutical Co., Ltd". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Nihon Pharmaceutical Co., Ltd, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Nihon Pharmaceutical Co., Ltd, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".